Recently, Tocris announced the release of some new Chemogenetic tools for Neuroscience research - PSEMs, pharmacologically selective effector molecules.
In Vitro Technologies Life Sciences division has a long history of supporting the Australian research community reaching back to 1958 and has developed a reputation for being one of the most dynamic and successful life science suppliers throughout Australia and New Zealand.
In Vitro Technologies are the premier supplier for cell biology and immunology research throughout Australia and New Zealand. Our range of cells, consumables, reagents, and laboratory equipment support your cell biology workflow in the fields of Cancer, Neuroscience, Immunology, Diabetes & Obesity, Cardiology, Pharmacology, and Drug Discovery. By partnering with world-class suppliers, In Vitro Technologies enables high quality, reproducible data, allowing researchers to accelerate discovery and publish high impact papers.
We are very pleased to announce that Polyplus-transfection® SA, has trusted In Vitro Technologies as their new exclusive distributor in Australia and New Zealand.
Located close to the University of Strasbourg in France, Polyplus-transfection® SA is a biotechnology company that develops and sells innovative, high efficiency transfection reagents for the delivery of nucleic acids in research, bioproduction and therapeutics.
We are very pleased to announce that Terumo BCT has appointed In Vitro Technologies as their new distributor in Australia and New Zealand effective 1 June 2018, supporting the Cell Therapy Technologies range of products.
ATCC's toxicological tools can also be used to identify responses to environmental insults or to screen pharmaceutical compounds. These cells are applicable for bench work and large-scale screening and are fully characterized and functionally tested.